• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种 SARS-CoV-2 疫苗后 AAV、抗 GBM 病和双阳性患者的临床表型。

Clinical phenotype of AAV, anti-GBM disease and double-positive patients after SARS-CoV-2 vaccination.

机构信息

Department of Nephrology, The First Medical Centre, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center of Kidney Diseases, Beijing, China.

Department of Nephrology, The First Medical Centre, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center of Kidney Diseases, Beijing, China.

出版信息

Autoimmun Rev. 2024 Apr;23(4):103521. doi: 10.1016/j.autrev.2024.103521. Epub 2024 Mar 13.

DOI:10.1016/j.autrev.2024.103521
PMID:38490282
Abstract

The number of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV), anti-glomerular basement membrane (GBM) disease and double-positive patients (DPPs) following the coronavirus disease 2019 (COVID-19) vaccine reported in the literature is increasing, we reviewed the reported cases of AAV, anti-GBM disease and DPPs subsequent to COVID-19 vaccination, and compared the disparities in DPPs who received the COVID-19 vaccination and those who did not. We did not observe any differences in clinical phenotype of AAV, anti-GBM disease and DPPs before and after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination.

摘要

文献报道的 COVID-19 疫苗接种后抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(AAV)、抗肾小球基底膜(GBM)疾病和双阳性患者(DPP)的数量正在增加,我们复习了 COVID-19 疫苗接种后报道的 AAV、抗 GBM 疾病和 DPP 病例,并比较了 COVID-19 疫苗接种和未接种 DPP 的差异。我们没有观察到 SARS-CoV-2 疫苗接种前后 AAV、抗 GBM 疾病和 DPP 的临床表型有任何差异。

相似文献

1
Clinical phenotype of AAV, anti-GBM disease and double-positive patients after SARS-CoV-2 vaccination.接种 SARS-CoV-2 疫苗后 AAV、抗 GBM 病和双阳性患者的临床表型。
Autoimmun Rev. 2024 Apr;23(4):103521. doi: 10.1016/j.autrev.2024.103521. Epub 2024 Mar 13.
2
Clinical characteristics and outcome of double-seropositive patients with anti-glomerular basement membrane antibodies and anti-neutrophil cytoplasmic antibodies.抗肾小球基底膜抗体和抗中性粒细胞胞质抗体双重阳性患者的临床特征和转归。
Int Immunopharmacol. 2024 Sep 10;138:112607. doi: 10.1016/j.intimp.2024.112607. Epub 2024 Jul 8.
3
Clinical features and prognosis of MPO-ANCA and anti-GBM double-seropositive patients.MPO-ANCA 和抗 GBM 双阳性患者的临床特征和预后。
Front Immunol. 2022 Oct 27;13:991469. doi: 10.3389/fimmu.2022.991469. eCollection 2022.
4
Renal and overall outcomes of double-positive (ANCA and anti-GBM antibodies) patients compared to ANCA-associated vasculitis patients with severe renal involvement: A multicenter retrospective study with systematic renal pathology analysis.与伴有严重肾脏受累的抗中性粒细胞胞浆抗体(ANCA)相关血管炎患者相比,双阳性(ANCA和抗肾小球基底膜抗体)患者的肾脏及总体预后:一项进行系统性肾脏病理分析的多中心回顾性研究。
Scand J Rheumatol. 2022 May;51(3):205-213. doi: 10.1080/03009742.2021.1920120. Epub 2021 Jun 25.
5
Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients.与单阳性患者相比,同时出现抗中性粒细胞胞浆抗体(ANCA)和抗肾小球基底膜(GBM)抗体双阳性的患者具有不同的肾脏存活率、复发频率和结局。
Kidney Int. 2017 Sep;92(3):693-702. doi: 10.1016/j.kint.2017.03.014. Epub 2017 May 12.
6
Case Report: ANCA-Associated Vasculitis Presenting With Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech COVID-19 mRNA Vaccination.病例报告:辉瑞-生物科技 COVID-19 mRNA 疫苗接种后出现横纹肌溶解症和寡免疫细胞性新月体性肾小球肾炎的抗中性粒细胞胞质抗体相关性血管炎。
Front Immunol. 2021 Sep 30;12:762006. doi: 10.3389/fimmu.2021.762006. eCollection 2021.
7
Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.抗中性粒细胞胞浆抗体(ANCA)和抗肾小球基底膜抗体双重阳性可预测抗中性粒细胞胞浆抗体相关性血管炎的终末期肾病:一项单中心的初步研究。
Clin Rheumatol. 2020 Mar;39(3):831-840. doi: 10.1007/s10067-019-04854-1. Epub 2019 Dec 4.
8
Performance of two strategies for urgent ANCA and anti-GBM analysis in vasculitis.两种用于血管炎中紧急抗中性粒细胞胞浆抗体(ANCA)和抗肾小球基底膜(GBM)分析策略的性能
Eur J Intern Med. 2014 Feb;25(2):182-6. doi: 10.1016/j.ejim.2013.11.011. Epub 2013 Dec 19.
9
Development of ANCA-associated vasculitis followed by SARS-CoV-2 vaccination in a patient with HLA-DRB1*09:01 allele.在 HLA-DRB1*09:01 等位基因患者中,抗中性粒细胞胞质抗体相关性血管炎继发于 SARS-CoV-2 疫苗接种。
Mod Rheumatol Case Rep. 2023 Jun 19;7(2):426-430. doi: 10.1093/mrcr/rxac093.
10
Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody.抗中性粒细胞胞浆抗体和抗肾小球基底膜抗体阳性的新月体性肾小球肾炎患者的特征和结局。
Clin Rheumatol. 2013 Sep;32(9):1317-22. doi: 10.1007/s10067-013-2268-5. Epub 2013 Apr 28.

引用本文的文献

1
Long COVID and the kidney.长期新冠与肾脏
Nat Rev Nephrol. 2025 Sep 4. doi: 10.1038/s41581-025-00997-4.
2
Multiple occurrences of membranous nephropathy complicated with anti-glomerular basement membrane antibody and anti-neutrophil cytoplasm antibody double-negative crescentic formation since the COVID-19 pandemic: A case series.自新冠疫情以来多次出现膜性肾病合并抗肾小球基底膜抗体和抗中性粒细胞胞浆抗体双阴性新月体形成:病例系列
J Int Med Res. 2025 Jul;53(7):3000605251357467. doi: 10.1177/03000605251357467. Epub 2025 Jul 23.
3
Daphnoretin inhibits glioblastoma cell proliferation and metastasis via PI3K/AKT signaling pathway inactivation.
瑞香素通过使PI3K/AKT信号通路失活来抑制胶质母细胞瘤细胞的增殖和转移。
J Cancer. 2024 Sep 9;15(17):5810-5827. doi: 10.7150/jca.98915. eCollection 2024.
4
Single Ferritin Nanocages Expressing SARS-CoV-2 Spike Variants to Receptor and Antibodies.表达针对受体和抗体的SARS-CoV-2刺突变体的单个铁蛋白纳米笼
Vaccines (Basel). 2024 Apr 23;12(5):446. doi: 10.3390/vaccines12050446.